Control of neglected tropical diseases

New England Journal of Medicine

Volumn 357, Issue 10, 2007, Pages 1018-1027

  Hotez, Peter J ^a,g   Molyneux, David H ^b   Fenwick, Alan ^c   Kumaresan, Jacob ^d   Sachs, Sonia Ehrlich ^e   Sachs, Jeffrey D ^e   Savioli, Lorenzo ^f  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d International Trachoma Initiative   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIMONIAL; ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; BENZNIDAZOLE; CLOFAZIMINE; DAPSONE; DB 289; DIETHYLCARBAMAZINE; EFLORNITHINE; IMIQUIMOD; IVERMECTIN; MEBENDAZOLE; MELARSOPROL; MILTEFOSINE; NIFURTIMOX; PAROMOMYCIN; PENTAMIDINE; PRAZIQUANTEL; RIFAMPICIN; SITAMAQUINE; SURAMIN; UNCLASSIFIED DRUG; VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN TRYPANOSOMIASIS; ASCARIASIS; BACTERIAL INFECTION; BURULI ULCER; CEREBROVASCULAR DISEASE; CHAGAS DISEASE; CLINICAL FEATURE; DEBRIDEMENT; DENGUE; DIARRHEA; DISEASE CONTROL; DISEASE TRANSMISSION; DRACUNCULIASIS; FILARIASIS; HEALTH CARE COST; HEALTH CARE POLICY; HOOKWORM INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISCHEMIC HEART DISEASE; LEISHMANIASIS; LEPROSY; LEPTOSPIROSIS; LOWER RESPIRATORY TRACT INFECTION; MAJOR DEPRESSION; MALARIA; MORBIDITY; MORTALITY; NEUROCYSTICERCOSIS; ONCHOCERCIASIS; PARASITOSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH SERVICE; REVIEW; SCABIES; SCHISTOSOMIASIS; SINGLE DRUG DOSE; SKIN GRAFT; STRONGYLOIDIASIS; TRACHOMA; TREMATODIASIS; TRICHURIASIS; TROPICAL DISEASE; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 34548422845     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra064142     Document Type: Review

References (78)

1. Molyneux DH. "Neglected" diseases but unrecognized successes - challenges and opportunities for infectious disease control. Lancet 2004;364:380-3.
2. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2005;2(11):e336.
3. Hotez PJ, Ottesen E, Fenwick A, Molyneux D. The neglected tropical diseases: the ancient afflictions of stigma and poverty and the prospects for their control and elimination. Adv Exp Biol Med 2006;582:22-33.
4. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, malaria. PLoS Med 2006;3(5):e102.
5. Hotez PJ. The "biblical diseases" and U.S. vaccine diplomacy. Brown World Aff J 2006;12:247-58.
6. Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, and hookworm. Lancet 2006;367:1521-32.
7. de Silva NR, Brooker S, Hotez PJ, Montresor A, Engels D, Savioli L. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003;19:547-51.
8. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: sytematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006;6:411-25.
9. Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol 2006;61:395-441.
10. World Health Organization. Global programme to eliminate lymphatic filariasis. WHO Wkly Epidemiol 2006;81:221-32. (Accessed August 10, 2007, at http://www.who.int/WER.)
11. International Trachoma Initiative home page. (Accessed August 10, 2007, at http://www.trachoma.org.)
12. Médecins sans Frontières. Campaign for access to essential medicines. (Accessed August 10, 2007, at http://www.accessmed-msf.org.)
13. Basáñez M-G, Pion SDS, Churcher TS, Breitling LP, Little MP, Boussinesq M. River blindness: a success story under threat? PLoS Med 2006;3(9):3371.
14. Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 2001;95:239-43.
15. WHO Expert Committee. Control of Chagas disease. World Health Organ Tech Rep Ser 2002;905:i-vi, 1-109.
16. International Federation of Anti-Leprosy Associations (ILEP) home page. (Accessed August 10, 2007, at http://www.ilep.org.uk.)
17. Févre EM, Picozzi K, Jannin J, Welburn SC, Maudlin I. Human African trypanosomiasis: epidemiology and control. Adv Parasitol 2006;61:167-221.
18. The Carter Center home page. (Accessed August 10, 2007, at http://www.cartercenter.org.)
19. Global Buruli Ulcer Initiative (GBUI) Geneva: World Health Organization. (Accessed August 10, 2007, at http://www.who.int/buruli/en.)
20. Lammie PJ, Fenwick A, Utzinger J. A blueprint for success: integration of neglected tropical disease control programmes. Trends Parasitol 2006;22:313-21.
21. Hotez PJ, Ferris MT. The antipoverty vaccines. Vaccine 2006;24:5787-99.
22. Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol 2006;22:552-7.
23. Annex Table 3: burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates for 2002. In: The world health report 2004 - changing history. Geneva: World Health Organization, 2004.
24. Remme JHF, Feenstra P, Lever PR, et al. Tropical diseases targeted for elimination: Chagas disease, lymphatic filariasis, onchocerciasis, and leprosy. In: Jamison DT, Breman JG, Measham AR, et al., eds. Disease control priorities in developing countries. 2nd ed. Oxford, England: Oxford University Press, 2006:433-50.
25. Bleakley H. Disease and development: evidence from hookworm eradication in the American South. Q J Econ 2007;122:73-117.
26. Ramaiah KD, Das PK, Michael E, Guyatt H. The economic burden of lymphatic filariasis in India. Parasitol Today 2000;16:251-3.
27. Frick KD, Hanson CL, Jacobson GA. Global burden of trachoma and economics of disease. Am J Trop Med Hyg 2003;69:5 Suppl:1-10.
28. Engels D, Savioli L. Public health strategies for schistosomiasis control. In: Secor WE, Colley DG, eds. World class parasites: Vol. X, schistosomiasis. New York: Springer, 2005:207-22.
29. Savioli L, Montresor A, Albonico M. Control strategies. In: Holland CV, Kennedy MW, eds. World class parasites: Vol. II, the geohelminths, ascaris, trichuris, and hookworm. New York: Springer, 2002: 25-37.
30. Molyneux DH. Elimination of transmission of lymphatic filariasis in Egypt. Lancet 2006;367:966-8.
31. Utzinger J, Zhou XN, Chen MG, Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop 2005;96:69-96.
32. Boatin BA, Richards FO Jr. Control of onchocerciasis. Adv Parasitol 2006;61:349-94.
33. Kumaresan J. Can blinding trachoma be eliminated by 20/20? Eye 2005;19:1067-73.
34. Mohammed KA, Molyneux DH, Albonico M, Rio F. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme. Trends Parasitol 2006;22:340-4.
35. Ramzy RMR, El Setouhy M, Helmy H, et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006;367:992-9. [Erratum, Lancet 2006;367:1980.]
36. Levine R, What Works Working Group. Controlling trachoma in Morocco. In: Millions saved: proven successes in global health. Washington, DC: Center for Global Development, 2004:83-9.
37. Kabatereine NB, Fleming FM, Nyandindi U, Mwanza JCL, Blair L. The control of schistosomiasis and soil-transmitted helminths in East Africa. Trends Parasitol 2006;22:332-9.
38. Fenwick A. New initiatives against Africa's worms. Trans R Soc Trop Med Hyg 2006;100:200-7.
39. World Health Organization. Global leprosy situation, 2005. Wkly Epidemiol Rec 2005;80:289-95.
40. World Health Organization. Dracunculiasis eradication. Wkly Epidemiol Rec 2006;81:173-83.
41. Ruiz-Tiben E, Hopkins DR. Dracunculiasis (Guinea worm disease) eradication. Adv Parasitol 2006;61:275-309.
42. World Health Organization. Deworming for health and development: report of the Third Global Meeting of the Partners for Parasite Control. Geneva: World Health Organization, 2005.
43. Brady MA, Hooper PJ, Ottesen EA. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol 2006;22:285-91.
44. Preventive chemotherapy in human helminthiasis. Geneva: World Health Organization, 2006.
45. WHO global health atlas. Geneva: World Health Organization. (Accessed August 13, 2007, at http://www.who.int/globalatlas.)
46. Raso G, Luginbuhl A, Adjoua CA, et al. Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int J Epidemiol 2004;33:1092-102.
47. Fenwick A, Molyneux D, Nantulya V. Achieving the Millennium Development Goals. Lancet 2005;365:1029-30.
48. Brooker S, Clements AC, Hotez PJ, et al. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J 2006;5:99.
49. Druilhe P, Tall A, Sokhna C. Worms can worsen malaria: towards a new means to roll back malaria? Trends Parasitol 2005;21:359-62.
50. Kjetland EF, Ndhlovu PD, Gorno E, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 2006;20:593-600.
51. Borkow G, Bentwich Z. HIV and helminth co-infection: is de-worming necessary? Parasite Immunol 2006;28:605-12.
52. Laxminarayan R, Mills AJ, Breman JG, et al. Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 2006;367:1193-208.
53. Canning D. Priority setting and the 'neglected' tropical diseases. Trans R Soc Trop Med Hyg 2006;100:499-504.
54. Yamagata Y, Nakagawa J. Control of Chagas disease. Adv Parasitol 2006;61:129-65.
55. Alvar J, Croft S, Olliaro P. Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 2006;61:223-74.
56. World Health Organization. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 2006;81:71-80.
57. Pan American Health Organization. XVth Meeting of the Southern Cone Intergovernmental Commision to Eliminate Triatoma infestans and Interrupt the Transmission of Transfusional Trypanosomiasis (INCOSUR-Chagas), Brasília, Brazil, 6-9 June 2006. (Accessed August 10, 2007, at http://www.paho.org/English/AD/DPC/CD/dch-incosur-xv.htm.)
58. Chirac P, Torreele E. Global framework on essential health R&D. Lancet 2006;367:1560-1.
59. El Sayed NM, Myler PJ, Blandin G, et al. Comparative genomics of trypanosomatid parasitic protozoa. Science 2005; 309:404-9.
60. Renslo AR, McKerrow JH. Drug discovery and development for neglected parasitic diseases. Nat Chem Biol 2006;2:701-10.
61. Croft SL, Barrett MP, Urbina JA. Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005;21:508-12.
62. Croft SL, Seifert K, Yardley V. Current scenario of drug development for leishmaniasis. Indian J Med Res 2006;123:399-410.
63. Albonico M, Engels D, Savioli L. Monitoring drug efficacy and early detection of drug resistance in human soil-transmitted nematodes: a pressing public health agenda for helminth control. Int J Parasitol 2004;34:1205-10.
64. Osei-Atweneboana MY, Eng JKL, Boakye DA, Gyapong JO, Prichard RK. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin after 19 years of treatment in endemic communities in Ghana. Lancet 2007;369:2021-9.
65. Hotez PJ. The National Institutes of Health roadmap and the developing world. J Investig Med 2004;52:246-7.
66. Weil GJ, Ramzy RMR. Diagnostic tools for filariasis elimination programs. Trends Parasitol 2007;23:78-82.
67. Xiao SH, Hui-Ming W, Tanner M, Utzinger J, Chong W. Tribendimidine: a promising, safe and broad-spectrum anthelmintic agent from China. Acta Trop 2005;94:1-14.
68. Hotez PJ, Bethony J, Bottazzi ME, Brooker S, Diemert D, Loukas A. New technologies for the control of human hookworm infection. Trends Parasitol 2006;22:327-31.
69. Taylor MJ, Bandi C, Hoerauf A. Wolbachia bacterial endosymbionts of filarial nematodes. Adv Parasitol 2005;60:247-86.
70. Capron A, Riveau G, Capron M, Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinica trials. Trends Parasitol 2005;21:143-9.
71. Coler RN, Reed SG. Second-generation vaccines against leishmaniasis. Trends Parasitol 2005;21:244-9.
72. Bergquist NR, Leonardo LR, Mitchell GF. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 2005;21:112-7.
73. Morel CM, Acharya T, Broun D, et al. Health innovation networks to help developing countries address neglected diseases. Science 2005;309:401-4.
74. Rabinovich NR. The renaissance in global health. Trends Parasitol 2006;22:277.
75. Fifty-Ninth World Health Assembly. Agenda item 11.11: Public health, innovation, essential health research and intellectual property rights: towards a global strategy and plan of action, 27 May 2006. Geneva: World Health Organization. (Accessed August 10, 2007, at http://www.who.int/mediacentre/ events/2006/wha59/en/index.html.)
76. Sachs JD, Hotez PJ. Fighting tropical diseases. Science 2006;311:1521.
77. Blackburn BG, Eigege A, Gotau H, et al. Successful integration of insecticide-treated bed net distribution with mass drug administration in central Nigeria. Am J Trop Med Hyg 2006;75:650-5.
78. Hunt P. The human right to the highest attainable standard to health: new opportunities and challenges. Trans R Soc Trop Med Hyg 2006;100:603-7.